(1r,4r)-4-(4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)-1H-imidazol-1-yl)cyclohexan-1-ol (1r,4r)-rel-4-(4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)-1H-咪唑-1-基)环己醇
CAS 193551-21-2 MFCD03792786
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SA} Approved Therapeutics/Drug C
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology, Cell Signaling and Neuroscience,
- Heterocycles
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Diversification Ready Pharma-Developed Compounds, Enzyme Inhibitors, Enzyme Inhibitors by Enzyme, GlaxoSmithKline, Kinase/Phosphatase Biology, Mitogen-Activated Protein Kinase (MAPK), P to Q, Protein Kinase Inhibitors, S, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors, p38 MAP Kinase Inhibitors, 生化试剂, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学, 酶、抑制剂和底物
产品应用
- SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. A protein kinase inhibitor
相关文献及参考
- Liu, Z., et al.: Stroke, 38, 146 (2007),
- Takahashi, K., et al.: J. Exp. Med., 201, 647 (2005),
- Underwood, D., et al.: J. Pharmacol. Exp. Ther., 293, 281 (2000),